These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 16341807)
1. Survival of patients with ovarian cancer due to a mismatch repair defect. Crijnen TE; Janssen-Heijnen ML; Gelderblom H; Morreau J; Nooij MA; Kenter GG; Vasen HF Fam Cancer; 2005; 4(4):301-5. PubMed ID: 16341807 [TBL] [Abstract][Full Text] [Related]
2. Survival of patients with Stage III colon cancer is improved in hereditary non-polyposis colorectal cancer compared with sporadic cases. A Danish registry based study. Brixen LM; Bernstein IT; Bülow S; Ehrnrooth E Colorectal Dis; 2013 Jul; 15(7):816-23. PubMed ID: 23350633 [TBL] [Abstract][Full Text] [Related]
3. Comparison of survival between patients with hereditary non polyposis colorectal cancer (HNPCC) and sporadic colorectal cancer. Haghighi MM; Vahedi M; Mohebbi SR; Pourhoseingholi MA; Fatemi SR; Zali MR Asian Pac J Cancer Prev; 2009; 10(2):209-12. PubMed ID: 19537885 [TBL] [Abstract][Full Text] [Related]
4. Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer. Boks DE; Trujillo AP; Voogd AC; Morreau H; Kenter GG; Vasen HF Int J Cancer; 2002 Nov; 102(2):198-200. PubMed ID: 12385019 [TBL] [Abstract][Full Text] [Related]
5. Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer. Bertario L; Russo A; Sala P; Eboli M; Radice P; Presciuttini S; Andreola S; Rodriguez-Bigas MA; Pizzetti P; Spinelli P Int J Cancer; 1999 Jan; 80(2):183-7. PubMed ID: 9935197 [TBL] [Abstract][Full Text] [Related]
6. The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer. Malander S; Rambech E; Kristoffersson U; Halvarsson B; Ridderheim M; Borg A; Nilbert M Gynecol Oncol; 2006 May; 101(2):238-43. PubMed ID: 16360201 [TBL] [Abstract][Full Text] [Related]
7. Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients. Stigliano V; Assisi D; Cosimelli M; Palmirotta R; Giannarelli D; Mottolese M; Mete LS; Mancini R; Casale V J Exp Clin Cancer Res; 2008 Sep; 27(1):39. PubMed ID: 18803843 [TBL] [Abstract][Full Text] [Related]
8. Distinct molecular profiles in Lynch syndrome-associated and sporadic ovarian carcinomas. Niskakoski A; Kaur S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P Int J Cancer; 2013 Dec; 133(11):2596-608. PubMed ID: 23716351 [TBL] [Abstract][Full Text] [Related]
9. Consideration of hereditary nonpolyposis colorectal cancer in BRCA mutation-negative familial ovarian cancers. South SA; Vance H; Farrell C; DiCioccio RA; Fahey C; Piver MS; Rodabaugh KJ Cancer; 2009 Jan; 115(2):324-33. PubMed ID: 19117025 [TBL] [Abstract][Full Text] [Related]
10. Risk of gynecologic cancers in Danish hereditary non-polyposis colorectal cancer families. Boilesen AE; Bisgaard ML; Bernstein I Acta Obstet Gynecol Scand; 2008; 87(11):1129-35. PubMed ID: 18972272 [TBL] [Abstract][Full Text] [Related]
11. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer. Loughrey MB; Waring PM; Tan A; Trivett M; Kovalenko S; Beshay V; Young MA; McArthur G; Boussioutas A; Dobrovic A Fam Cancer; 2007; 6(3):301-10. PubMed ID: 17453358 [TBL] [Abstract][Full Text] [Related]
12. [Expression of cyclooxygenase-2 and relationship with mismatch repair gene and microsatellite instability in hereditary non-polyposis colorectal cancer]. Zhang YH; Sheng JQ; Geng HG; Han M; Huang JS; Mu H; Han WL; Chen JG; Niu HL; Li AQ; Wu ZT; Li SR Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1377-81. PubMed ID: 19671325 [TBL] [Abstract][Full Text] [Related]
13. Survival from colorectal carcinoma in HNPCC families as compared to the general population in Lithuania--initial results. Elsakov P; Kurtinaitis J Fam Cancer; 2006; 5(4):369-71. PubMed ID: 16826317 [TBL] [Abstract][Full Text] [Related]
14. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome? Soliman PT; Broaddus RR; Schmeler KM; Daniels MS; Gonzalez D; Slomovitz BM; Gershenson DM; Lu KH J Clin Oncol; 2005 Dec; 23(36):9344-50. PubMed ID: 16361634 [TBL] [Abstract][Full Text] [Related]
15. Preoperative serum levels of the carcinoembryonic antigen in hereditary non-polyposis colorectal cancer compared to levels in sporadic colorectal cancer. Schiemann U; Günther S; Gross M; Henke G; Müller-Koch Y; König A; Muders M; Folwaczny C; Mussack T; Holinski-Feder E Cancer Detect Prev; 2005; 29(4):356-60. PubMed ID: 16122885 [TBL] [Abstract][Full Text] [Related]
16. Inverse effects of mucin on survival of matched hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer patients. You JF; Hsieh LL; Changchien CR; Chen JS; Chen JR; Chiang JM; Yeh CY; Hsieh PS; Fan CW; Liu CT; Tang R Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4244-50. PubMed ID: 16857798 [TBL] [Abstract][Full Text] [Related]
17. Gynecologic manifestations of hereditary nonpolyposis colorectal cancer. From inherited to sporadic disease. Taylor N; Mutch DG Oncology (Williston Park); 2006 Jan; 20(1):85-94; discussion 94-6, 100. PubMed ID: 16572595 [TBL] [Abstract][Full Text] [Related]
18. Survival analysis in families affected by hereditary non-polyposis colorectal cancer. Percesepe A; Benatti P; Roncucci L; Sassatelli R; Fante R; Ganazzi D; Bellacosa A; Genuardi M; Neri G; Viel A; Ponz de Leon M Int J Cancer; 1997 May; 71(3):373-6. PubMed ID: 9139871 [TBL] [Abstract][Full Text] [Related]
19. [Clinicopathologic characteristics, diagnosis, and treatment of 30 patients with hereditary nonpolyposis colorectal cancer]. Liu H; Yan Z; Liao G; Yin H; Xie X Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Aug; 34(8):757-61. PubMed ID: 19734583 [TBL] [Abstract][Full Text] [Related]
20. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Young J; Simms LA; Biden KG; Wynter C; Whitehall V; Karamatic R; George J; Goldblatt J; Walpole I; Robin SA; Borten MM; Stitz R; Searle J; McKeone D; Fraser L; Purdie DR; Podger K; Price R; Buttenshaw R; Walsh MD; Barker M; Leggett BA; Jass JR Am J Pathol; 2001 Dec; 159(6):2107-16. PubMed ID: 11733361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]